New York Life Investment Management LLC
Position in ESPR — Esperion Therapeutics, Inc.
CIK 1133639
New York, NY
Position in ESPR
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$0
New position
Shares Held
466,632
first reported quarter
Ownership
0.181%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026New York Life Investment Management LLC holds $14,583,179 across 6 Drug Manufacturers - Specialty & Generic names. ESPR ranks #6 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
71,601 | $5,145,247 | |
| 2 | VTRS |
Viatris Inc
|
306,470 | $4,866,743 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
14,832 | $2,499,785 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
61,404 | $1,511,152 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
1,034 | $560,252 | |
| 6 | ESPR |
Esperion Therapeutics, Inc.
This page
|
466,632 | $0 |
All Filings in ESPR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 466,632 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||